Ralliant (NYSE:RAL) Upgraded at Wall Street Zen

Key Points

• Wall Street Zen upgraded Ralliant from “buy” to “strong buy,” while MarketBeat’s analyst consensus remains “Moderate Buy” with a $75.70 target price.
• Ralliant reported quarterly EPS of $0.68, beating estimates of $0.63, on revenue of $567.8 million. The company issued FY 2026 EPS guidance of $2.76–$2.90.
• Shares opened at $63.72, compared with a 52-week range of $37.27–$75.41. Two executives sold shares under pre-arranged Rule 10b5-1 plans, while insider ownership stands at 0.42%.

Ralliant (NYSE:RAL - Get Free Report) was upgraded by Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report released on Saturday.

A number of other brokerages have also recently weighed in on RAL. Zacks Research upgraded shares of Ralliant from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, June 30th. Morgan Stanley upped their target price on shares of Ralliant from $68.00 to $85.00 and gave the company an "overweight" rating in a report on Tuesday, June 23rd. Citigroup increased their target price on shares of Ralliant from $81.00 to $82.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Oppenheimer raised their price target on Ralliant from $50.00 to $65.00 and gave the stock an "outperform" rating in a report on Wednesday, May 13th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of Ralliant in a research report on Friday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Ralliant has an average rating of "Moderate Buy" and a consensus target price of $75.70.

Ralliant Price Performance

Shares of NYSE RAL opened at $63.72 on Friday. The stock has a market cap of $7.05 billion, a P/E ratio of -5.87, a P/E/G ratio of 2.37 and a beta of 1.60. Ralliant has a twelve month low of $37.27 and a twelve month high of $75.41. The stock has a 50 day moving average of $68.94 and a two-hundred day moving average of $55.92. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75.

Ralliant (NYSE:RAL - Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, research analysts forecast that Ralliant will post 2.87 earnings per share for the current year.

Insider Buying and Selling

In other Ralliant news, SVP Karen M. Bick sold 6,062 shares of the firm's stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the sale, the senior vice president owned 31,668 shares of the company's stock, valued at approximately $2,280,096. This trade represents a 16.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of the business's stock in a transaction on Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the sale, the chief executive officer owned 251,967 shares in the company, valued at $18,088,710.93. The trade was a 4.88% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.42% of the stock is owned by insiders.

Hedge Funds Weigh In On Ralliant

A number of large investors have recently made changes to their positions in the stock. Dunhill Financial LLC purchased a new stake in Ralliant during the second quarter worth about $25,000. Global Retirement Partners LLC purchased a new position in Ralliant in the second quarter valued at about $35,000. Group One Trading LLC purchased a new position in Ralliant in the second quarter valued at about $36,000. Danske Bank A S purchased a new position in Ralliant in the fourth quarter valued at about $25,000. Finally, Persistent Asset Partners Ltd acquired a new stake in shares of Ralliant during the 2nd quarter valued at approximately $37,000.

Ralliant Company Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source